DaVita Inc.
DVA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.79 | 0.49 | -0.52 | 0.49 |
| FCF Yield | 7.05% | 1.88% | 0.30% | 3.09% |
| EV / EBITDA | 48.84 | 33.24 | 40.18 | 32.31 |
| Quality | ||||
| ROIC | 2.59% | 2.64% | 2.40% | 3.18% |
| Gross Margin | 31.80% | 33.08% | 30.52% | 32.46% |
| Cash Conversion Ratio | 2.72 | 1.18 | 1.10 | 1.57 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.79% | 3.89% | 3.59% | 3.35% |
| Free Cash Flow Growth | 232.16% | 453.19% | -90.25% | -43.85% |
| Safety | ||||
| Net Debt / EBITDA | 29.14 | 17.55 | 19.87 | 15.51 |
| Interest Coverage | 0.00 | 3.68 | 3.25 | 4.08 |
| Efficiency | ||||
| Inventory Turnover | 16.77 | 15.46 | 14.88 | 16.54 |
| Cash Conversion Cycle | 55.20 | 62.15 | 46.92 | 48.82 |